Lifshitz&Miller LLP Announces Investigation of ARI Network Services, Inc., DuPont Fabros Technology, Inc., Nexvet Biopharma Public Limited Company, PAREXEL International Corporation, Rice Energy Inc.

NEW YORK, July 3, 2017 /PRNewswire/ --

ARI Network Services, Inc. (ARIS)

Lifshitz & Miller announces investigation into possible breaches of fiduciary duties by the board in connection with the proposed sale of ARIS to private equity firm, True Wind Capital Management, LLC, for $7.10 in cash for each share of ARIS owned.

If you are an ARIS investor, and would like additional information about our investigation, please complete the Information Request Form or contact Joshua Lifshitz, Esq. by telephone at (516)493-9780 or e-mail at info@jlclasslaw.com.

DuPont Fabros Technology, Inc. (DFT)

Lifshitz & Miller announces investigation into possible breaches of fiduciary duties by the board in connection with the proposed sale of DFT to Digital Realty Trust, Inc. for 0.545 shares of Digital Realty for each share of DFT owned.

If you are a DFT investor, and would like additional information about our investigation, please complete the Information Request Form or contact Joshua Lifshitz, Esq. by telephone at (516)493-9780 or e-mail at info@jlclasslaw.com.

Nexvet Biopharma Public Limited Company (NVET)

Lifshitz & Miller announces investigation into possible breaches of fiduciary duties by the board in connection with the proposed sale of NVET to Zoetis Inc. for $6.72 in cash for each share of NVET owned.

If you are an NVET investor, and would like additional information about our investigation, please complete the Information Request Form or contact Joshua Lifshitz, Esq. by telephone at (516)493-9780 or e-mail at info@jlclasslaw.com.

PAREXEL International Corporation (PRXL)

Lifshitz & Miller announces investigation into possible breaches of fiduciary duties by the board in connection with the proposed sale of PRXL to Pamplona Capital Management, LLP for $88.10 in cash for each share of PRXL owned.

If you are a PRXL investor, and would like additional information about our investigation, please complete the Information Request Form or contact Joshua Lifshitz, Esq. by telephone at (516)493-9780 or e-mail at info@jlclasslaw.com.

Rice Energy Inc. (RICE)

Lifshitz & Miller announces investigation into possible breaches of fiduciary duties by the board in connection with the proposed sale of RICE to EQT Corporation for $5.30 in cash and 0.37 shares of EQT for each share of RICE owned.

If you are a RICE investor, and would like additional information about our investigation, please complete the Information Request Form or contact Joshua Lifshitz, Esq. by telephone at (516)493-9780 or e-mail at info@jlclasslaw.com.

SciClone Pharmaceuticals, Inc. (SCLN)

Lifshitz & Miller announces investigation into possible breaches of fiduciary duties by the board in connection with the proposed sale of SCLN to a consortium consisting of entities affiliated with GL Capital Management GP Limited, Bank of China Group Investment Limited, CDH Investments, Ascendent Capital Partners and Boying, for $11.18 in cash for each share of SCLN owned.

If you are an SCLN investor, and would like additional information about our investigation, please complete the Information Request Form or contact Joshua Lifshitz, Esq. by telephone at (516)493-9780 or e-mail at info@jlclasslaw.com.

ATTORNEY ADVERTISING.© 2017 Lifshitz & Miller LLP.  The law firm responsible for this advertisement is Lifshitz & Miller LLP, 821 Franklin Avenue, Suite 209, Garden City, New York 11530, Tel: (516)493-9780.  Prior results do not guarantee or predict a similar outcome with respect to any future matter.

Contact:

Joshua M. Lifshitz, Esq.
Lifshitz & Miller LLP
Phone:  516-493-9780
Facsimile: 516-280-7376
Email: info@jlclasslaw.com 

To view the original version on PR Newswire, visit:http://www.prnewswire.com/news-releases/lifshitzmiller-llp-announces-investigation-of-ari-network-services-inc-dupont-fabros-technology-inc-nexvet-biopharma-public-limited-company-parexel-international-corporation-rice-energy-inc-and-sciclone-pharmaceuticals--300483092.html

SOURCE Lifshitz & Miller Law Firm